First human drug trial in US for pill that reverses nuclear radiation poisoning trends now
View
comments
The first human trial of a pill to reverse nuclear radiation poisoning has been launched in the United States.
In the trial, 42 participants will receive the drug — named HOPO 14-1 — as an oral pill in Plymouth, Michigan, and then be monitored to see how well it is absorbed and removed from the body.
If the trial is successful, the treatment could become available by 2024, according to the National Institute on Allergy and Infectious Diseases (NIAID), which is funding the research.
News of the trial comes amid heightened fears about nuclear war as Russia continues to issue threats about using nukes as it continues its war in Ukraine.
The trial is set to take place in Plymouth, Michigan, and involves 42 participants aged 18 to 65 years old (stock picture)
Air defence missiles are seen impacting targets over Kyiv on Monday night. It was unclear whether these were the hypersonic 'Kinzhal' missiles, although Ukraine said it had downed six over the capital
President Putin repeatedly threatened to deploy nuclear weapons in the early days of the war, while his supporters have called for nukes to be used to obliterate US allies such as the United Kingdom.
Kevin Ryan, the former chief of staff for the US Army's Space and Missile Defense Command, warned today that bringing down Putin's 'unstoppable'
